ABU DHABI (ALETIHAD)
M42, a global tech-enabled health powerhouse, has won two prestigious awards at the Bonds, Loans & Sukuk Middle East Awards.
M42 secured both the M&A Deal of the Year and the Local Currency Loan Deal of the Year for the strategic acquisition of Diaverum.
The accolades demonstrate M42’s leadership in the healthcare industry and its commitment to advancing global health through innovative financing and strategic expansion.
The acquisition of Diaverum, a leading global renal care service provider from Bridgepoint Group in April 2023, made M42 the largest healthcare company in the Middle East.
The Diaverum deal instantly expanded M42's presence to 26 countries across Europe, Asia, South America and the Middle East.
The acquisition enabled the introduction of healthcare services and healthtech solutions in new markets while enhancing M42’s renal care offerings in the GCC.
Now, M42 has over 20,000 employees and more than 450 facilities.
The deal stands out due to its speed of execution and strategic alignment.
M42 showed meticulous negotiation and a non-cumbersome security package despite being the company's first debt raised since it was established in 2022.
The deal's structure strategically aligned repayments with the company's global operating cash flows, minimising currency risk and optimising debt management aligned with M42's long-term objectives.
Group Chief Financial Officer at M42, James Sibley, said, “This milestone is a great honour for both the M42 Investment team and the M42 Finance team. The successful execution of this deal demonstrates our dedication to reshaping the future of health through technology and strategic growth. We are proud of this recognition and remain focused on our mission to deliver the highest level of personalised, precise and preventive health solutions globally.”